Pneumococcal

Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL

Pneumococcal vaccine, polysaccharide and conjugate, research, development, preclinical, clinical, safety, epidemiology, cost, and economics.

Back to Sections

Modify your search

Advanced

Human Vaccines & Immunotherapeutics sections

  • Showing 1-10 of 24 results for search:

Filters
Modify your search
Download citations Download PDFs
  5. A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)Open Access
    Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi “Lucy” Li, Yae-Jean Kim, Yun-Kyung Kim, Jin Lee, Ji Young Park, Dong Hyun Kim, GyongSeon Yang, Hyunjung Lim, Jin Oh Kim, Robert Lupinacci, Tina M. Sterling, Marissa Wilck, Alejandra Esteves-Jaramillo & Natalie Banniettis
    Human Vaccines & Immunotherapeutics, Volume 20, 2024 - Issue 1
    Article | Published online: 18 Mar 2024 | Views: 908
    Full Text
  10. Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trialOpen Access
    Michael W. Simon, Regine Bataille, Nicole S. Caldwell, Bradford D. Gessner, Luis Jodar, Erik Lamberth, Yahong Peng, Daniel A. Scott, Lanyu Lei, Peter C. Giardina, William C. Gruber, Kathrin U. Jansen, Allison Thompson & Wendy Watson
    Human Vaccines & Immunotherapeutics, Volume 19, 2023 - Issue 2
    Article | Published online: 05 Nov 2023 | Views: 690
    Full Text